Literature DB >> 16221231

Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis.

Gary S Hill1, Michel Delahousse, Dominique Nochy, Jean Bariéty.   

Abstract

BACKGROUND: A recently proposed reclassification of lupus nephritis divides class IV (diffuse proliferative) lupus nephritis into those cases with predominantly segmental proliferative lesions (class IV-S) and those with predominantly global proliferative lesions (class IV-G). This report explores the validity of this distinction and possible differences in pathogenesis between the 2 types of lesions.
METHODS: Patients from a previously reported series of severe lupus nephritis, with initial biopsies (Bx1) and control biopsies (Bx2) at 6 months after induction therapy were reclassified according to the newly proposed classification. From the original series of 65 patients, 15 patients were reclassified as having class IV-S lesions and 31 patients class IV-G lesions. Clinical data at both biopsies and follow-up were available on all patients selected.
RESULTS: Patients with IV-G lesions had worse proteinuria, lower serum hemoglobins, lower CH50s, and likely higher SCrs (P = .06) and lower C3s (P = .08) than class IV-S patients. Serum CH50 and C3 correlated negatively with severity of class IV-G lesions, but not at all with class IV-S lesions. Patients with class IV-G lesions had greater overall immune deposits and subendothelial deposits on IF and greater hyaline deposits on light microscopy. By contrast, class IV-S showed predominant mesangial deposits and a much higher rate of glomerular fibrinoid necroses (13.3 +/- 15.3% vs. 5.6 +/- 8.0% of viable glomeruli, P = .03). Other distinctions included the fact that membranoproliferative features were found only in class IV-G lesions, and glomerular monocyte/macrophages were much more frequent in this group than in class IV-S lesions (1.77 +/- 0.92 vs. 0.86 +/- 0.77, P = .008). Finally, class IV-G frequently involved all viable glomeruli (74.2% of cases), whereas segmental proliferative lesions never did (P < .0001). Survivals from doubling of SCr at 10 years did not differ between the 2 types at Bx1: 72.5% segmental versus 60.4% global, P= .53. However, among those with persistent lesions at Bx 2 (11 IV-S and 9 IV-G), there was a dramatic difference in 10-year survivals between IV-S lesions (63.6%) and IV-G lesions (0%), P = .08.
CONCLUSION: There are definite clinical and morphologic differences between class IV-S and IV-G lesions. Data suggest that class IV-G lesions behave as an immune complex disease, having positive correlations with extent of immune deposits and negative correlations with serum complement levels, the model traditionally assumed for lupus nephritis as a whole. However, in class IV-S lesions, the presence of proportionally greater glomerular fibrinoid necroses and lack of correlation with extent of immune deposits suggest that these lesions may have a different pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16221231     DOI: 10.1111/j.1523-1755.2005.00688.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  36 in total

1.  Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes.

Authors:  Catharina M Haring; Anke Rietveld; Jan A J G van den Brand; Jo H M Berden
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

Review 2.  Histopathology of lupus nephritis.

Authors:  Konstantinos Giannakakis; Tullio Faraggiana
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

3.  Renal biopsy at the onset of clinical lupus nephritis: can it yield useful information?

Authors:  Jim Oates
Journal:  J Rheumatol       Date:  2007-02       Impact factor: 4.666

4.  ANCA positivity at the time of renal biopsy is associated with chronicity index of lupus nephritis.

Authors:  Jung Yoon Pyo; Seung Min Jung; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Rheumatol Int       Date:  2019-02-26       Impact factor: 2.631

Review 5.  Nanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imaging.

Authors:  Joshua M Thurman; Natalie J Serkova
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

6.  The NZM2410-derived lupus susceptibility locus Sle2c1 increases Th17 polarization and induces nephritis in fas-deficient mice.

Authors:  Zhiwei Xu; Carla M Cuda; Byron P Croker; Laurence Morel
Journal:  Arthritis Rheum       Date:  2011-03

Review 7.  Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Authors:  Feng Yu; Mark Haas; Richard Glassock; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

8.  Pauci-immune and immune glomerular lesions in kidney transplants for systemic lupus erythematosus.

Authors:  Shane M Meehan; Anthony Chang; Amandeep Khurana; Rajendra Baliga; Pradeep V Kadambi; Basit Javaid
Journal:  Clin J Am Soc Nephrol       Date:  2008-06-18       Impact factor: 8.237

9.  Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.

Authors:  Samih H Nasr; Vivette D D'Agati; Hye-Ran Park; Paul L Sterman; Juan D Goyzueta; Robert M Dressler; Shawn M Hazlett; Robert N Pursell; Christopher Caputo; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

Review 10.  Usefulness of ISN/RPS classification of lupus nephritis.

Authors:  Ken-Ei Sada; Hirofumi Makino
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.